ADAC, Eastern Isotopes form alliance
ADAC Laboratories has forged an exclusive vendor agreement with PET radiopharmaceutical manufacturer Eastern Isotopes. The partnership gives ADAC access to 5.5 millicurie doses of FDG, which it will buy at a discount from Eastern Isotopes, and allows it
ADAC Laboratories has forged an exclusive vendor agreement with PET radiopharmaceutical manufacturer Eastern Isotopes. The partnership gives ADAC access to 5.5 millicurie doses of FDG, which it will buy at a discount from Eastern Isotopes, and allows it to supply its molecular coincidence detection/attenuation correction (MCD/AC) and CPET customers. ADACs FDG imaging products do not require 10 millicurie doses of the radioisotope, as competitive products do, according to the Milpitas, CA, company.
Based in Sterling, VA, Eastern Isotopes was established in 1995 as a distributor of SPECT pharmaceuticals. Last year, the firm began to produce high-energy tracers, particularly FDG, for therapy, oncology, cardiology, and neurology.
With the deal, ADAC continues its push into the PET market, capitalizing on the momentum created by its September purchase of partner UGM Medical, a developer and manufacturer of PET devices (SCAN 9/29/99). The two firms codeveloped ADACs MCD high-energy imaging option for gamma cameras (SCAN 12/14/94).
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
